Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| CPFX2090 | C28H28ClNO6 | 1429439-25-7 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| Repaglinide；AG-EE 623ZW;AG-EE 388 ZW | C27H36N2O4 | 135062-02-1 | Details |
| CPPG；(RS)-CPPG | C11H14NO5P | 183364-82-1 | Details |
| CPPHA | C22H15ClN2O4 | 693288-97-0 | Details |
| CPUY074020 | C25H28N4O2 | 902279-44-1 | Details |
| CRA-026440 | C23H24N4O4 | 847460-34-8 | Details |
| CRAC intermediate 1；5-(S)-Fluorowillardiine | C10H7F2N3O | 1249343-86-9 | Details |
| CRAC intermediate 2 | C11H7F6N3 | 123066-64-8 | Details |
| Crocetine dimethyl ester；Dimethylcrocetin | C22H28O4 | 5892-54-6 | Details |
| CRS400393 | C18H20Cl2N2OS | 2253175-64-1 | Details |
| CRT0066854 hydrochloride | C24H26ClN5S | 2250019-91-9 | Details |
| CRTh2 antagonist 2 | C26H23ClN4O3 | 780763-95-3 | Details |
| CRTh2 antagonist 3 | C19H20N2O3S | 312928-72-6 | Details |
| CRTH2-IN-1；Ramatroban analog | C21H21FN2O4S | 926661-54-3 | Details |
| CS-003 Free base | C34H38Cl2N2O6S | 191672-52-3 | Details |
| CS-722 Free base | C16H19ClN2O4 | 749179-13-3 | Details |
| CSF1R-IN-1 | C25H20F3N5O2 | 2095849-04-8 | Details |
| CSRM617 | C10H13N3O5 | 787504-88-5 | Details |
| CT-721 | C30H29ClN6O | 1388710-60-8 | Details |
| Samuraciclib hydrochloride；ICEC0942 hydrochloride;CT7001 hydrochloride | C22H31ClN6O | 1805789-54-1 | Details |
| CU-CPT17e | C27H24N2O8 | 2109805-75-4 | Details |
| Perphenazine；Perphenazin;Trilafon;Etaperazine | C21H26ClN3OS | 58-39-9 | Details |
| CUDA | C19H36N2O3 | 479413-68-8 | Details |
| Curcumin-d6；Curcumin D6;Natural Yellow 3 D6;Turmeric yellow D6;Diferuloylmethane D6 | C21H20O6 | 1246833-26-0 | Details |
| CWHM-1008 | C22H26F3N3O | 2362539-97-5 | Details |
| CWHM-1552 | C22H27F2N3O | 2368253-58-9 | Details |
| CWP232228 | C33H37N7NaO7P | 1144044-02-9 | Details |
| CXCR2-IN-1 | C19H20Cl2FN3O4S | 1873376-49-8 | Details |
| CXCR7 modulator 1 | C48H57F2N7O7S | 2231812-31-8 | Details |
| CXCR7 modulator 2 | C29H42N6O3 | 2227426-37-9 | Details |
| CY 208-243 | C19H18N2 | 100999-26-6 | Details |
| Cyclic-di-GMP；c-di-GMP;cyclic diguanylate;5GP-5GP | C20H24N10O14P2 | 61093-23-0 | Details |
| Cycloartenol | C30H50O | 469-38-5 | Details |
| H3 receptor antagonist 1 | C20H28F2N2O | 935840-13-4 | Details |
| S1PR1-MO-1 | C25H29N3O3 | 1149727-61-6 | Details |
| Cyclobuxine D | C25H42N2O | 2241-90-9 | Details |
| Cyclodrine hydrochloride | C19H30ClNO3 | 78853-39-1 | Details |
| LTB4-IN-1 | C26H30N2O4S | 133012-00-7 | Details |
| NEP-In-1 | C21H30ClNO4 | 465527-94-0 | Details |
| Cyclophilin inhibitor 1 | C31H39N5O7 | 1509904-96-4 | Details |
| Zolmitriptan；311C90;BW-311C90 | C16H21N3O2 | 139264-17-8 | Details |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | C28H39F3N8O9 | 199807-33-5 | Details |
| CYM 9484 | C27H31N3O3S2 | 1383478-94-1 | Details |
| CYP11B2-IN-1 | C18H18FN3O | 1356479-78-1 | Details |
| CYP17-IN-1 | C18H17FN2S | 2093317-51-0 | Details |
| CL656；c-[2’FdAMP(S)-2’FdIMP(S)] | C20H21F2N9O9P2S2 | 1951464-79-1 | Details |
| Cletoquine；Desethylhydroxychloroquine | C16H22ClN3O | 4298-15-1 | Details |
| Cletoquine oxalate；Desethylhydroxychloroquine oxalate | C18H24ClN3O5 | 14142-64-4 | Details |
| CLK1-IN-1 | C24H16FN5O | 2123491-32-5 | Details |
| Clocapramine dihydrochloride hydrate；3-Chlorocarpipramine hydrochloride hydrate;Clocapramine hydrochloride hydrate | C28H40Cl2N4O2 | 60789-62-0 | Details |
| Clocapramine；Clocarpramine;3-Chlorocarpipramine | C28H37ClN4O | 47739-98-0 | Details |
| Closthioamide | C29H38N6O2S6 | 1227367-59-0 | Details |
| Clozic；Clobuzarit;ICI 55897 | C17H17ClO3 | 22494-47-9 | Details |
| Theophylline monohydrate；Quibron | C7H10N4O3 | 5967-84-0 | Details |
| Apramycin sulfate；Nebramycin II;Ai3-29795 | C21H43N5O15S | 65710-07-8 | Details |
| CM-579 | C29H40N4O3 | 1846570-40-8 | Details |
| CM-675 | C31H32N6O3 | 1872466-47-1 | Details |
| Clomipramine D3 | C18H19ClD3N3 | 136765-29-2 | Details |
| Clomipramine D3 hydrochloride | C19H24Cl2N2 | 1398065-86-5 | Details |
| CMF019 | C25H33N3O3S | 1586787-08-7 | Details |
| CMI-392 | C31H37ClN2O8S | 205654-37-1 | Details |
| CMK | C18H19ClN4O2 | 821794-90-5 | Details |
| CMLD010509；SDS-1-021 | C27H26BrNO7 | 256497-58-2 | Details |
| CMLD012072 | C32H32N2O7 | 2368900-33-6 | Details |
| CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
| CMLD012612 | C31H33N3O7 | 2368900-35-8 | Details |
| L-Glutathione reduced；Glutathion;Isethion;GSH;Glutathione;Tathion;γ-L-Glutamyl-L-cysteinyl-glycine | C10H17N3O6S | 70-18-8 | Details |
| CMP-5 | C21H21N3 | 880813-42-3 | Details |
| CMP-Sialic acid sodium salt；CMP-Neu5Ac sodium salt | C20H32N4NaO16P | 1007117-62-5 | Details |
| CNS-5161 hydrochloride；CNS 5161A | C16H19Cl2N3S2 | 160756-38-7 | Details |
| CNT2 inhibitor-1 | C23H24N6O4 | 880155-70-4 | Details |
| CNX-500 | C48H68N10O9S | 1202758-21-1 | Details |
| CO23 | C19H18I2N2O4 | 1370363-74-8 | Details |
| Cobimetinib (R-enantiomer)；XL-518 R-enantiomer;GDC-0973 R-enantiomer;Cobimetinib R-enantiomer | C21H21F3IN3O2 | 934660-94-3 | Details |
| Coenzyme A | C21H36N7O16P3S | 85-61-0 | Details |
| COH34 analog 1 | C18H15NO3S | 314248-24-3 | Details |
| COH34 | C18H15NOS | 906439-72-3 | Details |
| Glutathione oxidized；L-Glutathione oxidized;Bi(glutathion-S-yl);Glutathione disulfide;Oxidized glutathione;GSSG;L(-)-Glutathione | C20H32N6O12S2 | 27025-41-8 | Details |
| Vitamin D2；Ergocalciferol;Calciferol;Ercalciol | C28H44O | 50-14-6 | Details |
| Col003 | C14H11NO4 | 328565-16-8 | Details |
| Collagen proline hydroxylase inhibitor-1 | C24H21N5O4 | 223663-32-9 | Details |
| Collagen proline hydroxylase inhibitor | C18H18N4O4 | 223666-07-7 | Details |
| Complement C5-IN-1 | C24H32N2O6 | 2365402-67-9 | Details |
| Corin | C26H28N4O2 | 1808113-09-8 | Details |
| Cot inhibitor-1 | C27H27Cl2FN8 | 915365-57-0 | Details |
| Cot inhibitor-2 | C26H25Cl2FN8 | 915363-56-3 | Details |
| Coumetarol；Ph 137;Dicumoxane | C21H16O7 | 4366-18-1 | Details |
| CP-28888；CP 28888-27 | C40H76N2 | 69938-75-6 | Details |
| CP-409092 hydrochloride | C17H20ClN3O2 | 225240-86-8 | Details |
| CP-409092 | C17H19N3O2 | 194098-25-4 | Details |
| Valacyclovir hydrochloride；Valaciclovir hydrochloride;Valaciclovir HCl | C13H21ClN6O4 | 124832-27-5 | Details |
| CP-547632 hydrochloride | C20H25BrClF2N5O3S | 252003-71-7 | Details |
| CP-547632 | C20H24BrF2N5O3S | 252003-65-9 | Details |
| CP-809101 hydrochloride | C15H18Cl2N4O | 1215721-40-6 | Details |
| CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
| CP-96486 | 139401-45-9 | Details |
| CP-060 | C30H42N2O5S | 180090-15-7 | Details |
| CPA inhibitor；Carboxypeptidase inhibitor | C18H19NO4 | 223532-02-3 | Details |
| CPDA | C20H15ClF2N2O2 | 1415834-63-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 | ||||